Novo Nordisk Management
Management criteria checks 3/4
Novo Nordisk's CEO is Lars Jorgensen, appointed in Jan 2017, has a tenure of 7.25 years. total yearly compensation is DKK60.10M, comprised of 28.5% salary and 71.5% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth DKK81.23M. The average tenure of the management team and the board of directors is 3.2 years and 6.1 years respectively.
Key information
Lars Jorgensen
Chief executive officer
kr.60.1m
Total compensation
| CEO salary percentage | 28.5% |
| CEO tenure | 7.3yrs |
| CEO ownership | 0.002% |
| Management average tenure | 3.2yrs |
| Board average tenure | 6.1yrs |
Recent management updates
Recent updates
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?
Apr 14
Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?
Mar 18Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings
Dec 30Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly
Dec 12Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)
Nov 24Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)
Aug 20These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely
Aug 02Estimating The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)
May 22These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely
May 04Novo Nordisk (CPH:NOVO B) Will Pay A Larger Dividend Than Last Year At DKK8.15
Feb 04Novo Nordisk (CPH:NOVO B) Has A Rock Solid Balance Sheet
Feb 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | kr.84b |
| Sep 30 2023 | n/a | n/a | kr.75b |
| Jun 30 2023 | n/a | n/a | kr.67b |
| Mar 31 2023 | n/a | n/a | kr.61b |
| Dec 31 2022 | kr.60m | kr.17m | kr.56b |
| Sep 30 2022 | n/a | n/a | kr.53b |
| Jun 30 2022 | n/a | n/a | kr.51b |
| Mar 31 2022 | n/a | n/a | kr.49b |
| Dec 31 2021 | kr.58m | kr.17m | kr.48b |
| Sep 30 2021 | n/a | n/a | kr.46b |
| Jun 30 2021 | n/a | n/a | kr.44b |
| Mar 31 2021 | n/a | n/a | kr.43b |
| Dec 31 2020 | kr.57m | kr.14m | kr.42b |
| Sep 30 2020 | n/a | n/a | kr.42b |
| Jun 30 2020 | n/a | n/a | kr.41b |
| Mar 31 2020 | n/a | n/a | kr.40b |
| Dec 31 2019 | kr.55m | kr.14m | kr.39b |
| Sep 30 2019 | n/a | n/a | kr.39b |
| Jun 30 2019 | n/a | n/a | kr.38b |
| Mar 31 2019 | n/a | n/a | kr.38b |
| Dec 31 2018 | kr.41m | kr.11m | kr.39b |
| Sep 30 2018 | n/a | n/a | kr.38b |
| Jun 30 2018 | n/a | n/a | kr.39b |
| Mar 31 2018 | n/a | n/a | kr.39b |
| Dec 31 2017 | kr.32m | kr.9m | kr.38b |
Compensation vs Market: Lars's total compensation ($USD8.58M) is above average for companies of similar size in the Danish market ($USD4.16M).
Compensation vs Earnings: Lars's compensation has been consistent with company performance over the past year.
CEO
Lars Jorgensen (57 yo)
7.3yrs
Tenure
kr.60,100,000
Compensation
Mr. Lars Fruergaard Jorgensen has been Chief Executive Officer and President of Novo Nordisk A/S since January 2017and serves as its Member of Management Board. Mr. Jorgensen served as Deputy Chair of the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.3yrs | kr.60.10m | 0.0021% DKK 81.2m | |
| Executive VP | 6.2yrs | kr.21.50m | 0.000010% DKK 390.5k | |
| Executive VP of Product Supply | no data | kr.22.00m | 0.000060% DKK 2.3m | |
| Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board | no data | kr.21.30m | 0% DKK 0 | |
| Executive VP of Development & Member of the Management Board | 3.3yrs | kr.20.90m | no data | |
| EVP of Research & Early Development | 3.1yrs | kr.20.90m | no data | |
| Executive VP of International Operations & Member of the Management Board | no data | no data | 0.0024% DKK 92.2m | |
| Executive VP of North America Operations & Member of Management Board | no data | no data | no data | |
| Executive VP | no data | no data | no data | |
| Executive VP of Global People & Organisation and Member of Management Board | 1.1yrs | no data | no data | |
| Executive VP of Corporate Development & Member of Management Board | 1.1yrs | no data | no data | |
| CVP & Head of Investor Relations | no data | no data | no data |
3.2yrs
Average Tenure
53yo
Average Age
Experienced Management: NOVO B's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 9.1yrs | kr.1.80m | no data | |
| Independent Chairman of the Board | 7.1yrs | kr.3.10m | no data | |
| Vice Chairman of the Board | 3.1yrs | kr.2.00m | no data | |
| Independent Director | 5.1yrs | kr.2.00m | no data | |
| Independent Director | 6.1yrs | kr.1.70m | no data | |
| Independent Director | 6.1yrs | kr.1.40m | no data | |
| Non-Independent Director | 7.1yrs | kr.1.20m | no data | |
| Independent Director | 2.1yrs | kr.1.30m | no data | |
| Employee Representative Director | 2.1yrs | kr.800.00k | 0.00019% DKK 7.4m | |
| Employee Non-Independent Representative Director | 6.1yrs | kr.1.20m | no data | |
| Employee Representative Non-Independent Director | 6.3yrs | kr.1.00m | no data | |
| Employee Representative Director | 2.1yrs | kr.800.00k | no data |
6.1yrs
Average Tenure
57.5yo
Average Age
Experienced Board: NOVO B's board of directors are considered experienced (6.1 years average tenure).